Molecular target
β3-Adrenergic Receptor
Bladder detrusor muscle adrenergic receptor; agonism (mirabegron) relaxes the bladder during filling — the mechanism behind the newer non-anticholinergic OAB class. Also expressed on adipocytes (thermogenesis).
Educational use only. This page summarizes published research and traditional-use records for educational purposes. It does not diagnose, treat, cure, or prevent any disease. Do not start, stop, or change medications based on this information. Discuss any decisions about therapies — pharmaceutical or botanical — with a qualified clinician who knows your medical history.
No PHI / HIPAA notice: Do not share Protected Health Information (PHI) of any patient on this site — including names, dates of birth, addresses, MRNs, or any identifying information. Use abstract case framing only. Sharing PHI with non-covered entities risks HIPAA violation regardless of platform capability.
Pharmaceutical agents
Drugs that act on β3-Adrenergic Receptor
These medications have β3-Adrenergic Receptor among their molecular targets. Sharing a target is a mechanistic relationship — it does not make any plant below an alternative to, or substitute for, these drugs.
Botanical connections
Plants whose compounds act on β3-Adrenergic Receptor
Each plant below contains a named compound documented to act on β3-Adrenergic Receptor. The compound and the reason for the connection are shown on every edge — a shared mechanism, not a therapeutic equivalence.
- p-Synephrinephenethylamine
Selective β3-adrenergic agonist with mild α1 activity — promotes lipolysis in adipose tissue. Doesn't cross the blood-brain barrier as readily as ephedrine, but vascular α1 activity is the source of cardiovascular safety concerns.